What is SeeTrue Technology?
SeeTrue Technology, through its specialization in biomedical research, is at the forefront of developing innovative solutions aimed at enhancing scientific and healthcare procedures. The company's core offerings empower researchers and medical professionals by providing precision tools that facilitate advancements in disease prevention, treatment delivery, and fundamental research. Their technology is particularly impactful in areas such as genetic research, biotechnology, and fertility treatments, where accuracy and efficiency are paramount. By reducing barriers and costs for researchers, SeeTrue Technology contributes to accelerating groundbreaking medical discoveries and improving patient outcomes.
How much funding has SeeTrue Technology raised?
SeeTrue Technology has raised a total of $100K across 1 funding round:
Private Equity
$100K
Private Equity (2023): $100K with participation from Tedco
Key Investors in SeeTrue Technology
Tedco
TEDCO, the Maryland Technology Development Corporation, focuses on fostering an inclusive entrepreneurial innovation ecosystem by identifying, investing in, and growing technology and life science-based companies within Maryland.
What's next for SeeTrue Technology?
The substantial backing and recent strategic investment suggest SeeTrue Technology is poised for significant scaling and further innovation. As a company operating in the late-stage funding phase, this capital is likely to be deployed towards expanding its product development, enhancing manufacturing capabilities, and broadening its market reach. Strategic partnerships and further research into novel applications of their microcapillary needle technology are anticipated. The company's focus on precision and reliability in biomedical research positions it for continued growth and influence within the life sciences industry.
See full SeeTrue Technology company page
